A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin
Clinical trial NCT01729403 · COMPLETED
Trial details
- NCT number
- NCT01729403
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-09-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.